Sara McLaury
Family · Sebring, FLNPI 1528817533
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 9.1% — the pattern of someone who eats at a lot of different presentations.
Across 85 payments — averaging $21.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$165
- Daiichi Sankyo Inc.$161
- Pfizer$131
- Exelixis Inc.$126
- AstraZeneca$123
- Johnson & Johnson$115
- plus $1000 from 22 others
What the payments were for
- Food & beverage$1,72295%
- Education$995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $165 |
| Daiichi Sankyo Inc. | 6 | $161 |
| Pfizer | 12 | $131 |
| Exelixis Inc. | 3 | $126 |
| AstraZeneca(2 entities) | 6 | $123 |
| Johnson & Johnson | 5 | $115 |
| Bayer | 6 | $106 |
| Incyte Corporation | 4 | $88 |
| Array Biopharma Inc | 4 | $87 |
| Bristol Myers Squibb | 2 | $68 |
| Merck | 3 | $61 |
| Novartis | 3 | $59 |
| Kyowa Kirin, Inc. | 2 | $57 |
| Geron Corporation | 2 | $50 |
| Eisai Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $49 |
| Genentech USA, Inc. | 3 | $48 |
| Pharmaessentia USA Corporation | 2 | $40 |
| AVEO Pharmaceuticals, Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Taiho Oncology, Inc. | 1 | $32 |
| Stemline Therapeutics Inc. | 1 | $28 |
| Tersera Therapeutics LLC | 1 | $25 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Recordati_rare_diseases_inc. | 1 | $15 |
| Adaptive Biotechnologies Corporation | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
How this compares
$1,821 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Other family in Sebring
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.